Can Routine Data Be Used to Determine the Target Population of Patients With Type 2 Diabetes in Early Benefit Assessments in Germany?
Gesundheitswesen - Germany
doi 10.1055/a-0948-5301
Full Text
Open PDFAbstract
Available in full text
Date
August 26, 2019
Authors
Publisher
Georg Thieme Verlag KG